Inventor · disambiguated record
Duncan Taylor
Also filed as: TAYLOR DUNCAN · TAYLOR DUNCAN P · TAYLOR DUNCAN PAUL
20 granted patents·29 pending applications·469 citations·filing 1989–2019
96Inventor score
Top patents by PatentIndex Score
49 records- 0195US8741950B2Methods for treating or preventing fatigueKHAYRALLAH MOISE A·Filed 2010·Granted Jun 3, 2014·57 cites·15 claims
- 0295US6703389B2Method of treating chronic painUPJOHN CO·Filed 2001·Granted Mar 9, 2004·52 cites·9 claims
- 0395US6610690B2Method of treating or preventing fibromyalgia and other somatoform disorders with a highly selective norepinephrine reuptake inhibitorUPJOHN CO·Filed 2002·Granted Aug 26, 2003·43 cites·39 claims
- 0495US6465458B1Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitorUPJOHN CO·Filed 2000·Granted Oct 15, 2002·56 cites·32 claims
- 0594US8623913B2Methods for treating restless legs syndromeMELNICK SUSAN MARIE·Filed 2010·Granted Jan 7, 2014·61 cites·4 claims
- 0694US7338953B2Method of treating chronic fatigue syndromeUPJOHN CO·Filed 2006·Granted Mar 4, 2008·19 cites·9 claims
- 0794US7276503B2Method of treating chronic fatigue syndromeUPJOHN CO·Filed 2006·Granted Oct 2, 2007·20 cites·32 claims
- 0894US7241762B2Method of treating peripheral neuropathyUPJOHN CO·Filed 2006·Granted Jul 10, 2007·19 cites·9 claims
- 0993US7317011B2Method of treating peripheral neuropathyPHARMACIA & UPJOHN·Filed 2004·Granted Jan 8, 2008·34 cites·16 claims
- 1093US6642235B2Method of treating migraine headaches with a highly selective noreoinephrine reuptake inhibitorUPJOHN CO·Filed 2002·Granted Nov 4, 2003·30 cites·39 claims
- 1190US7723334B2Highly selective norepinephrine reuptake inhibitors and methods of using the samePFIZER·Filed 2007·Granted May 25, 2010·10 cites·17 claims
- 1288US6987107B2Method of treating incontinenceUPJOHN CO·Filed 2002·Granted Jan 17, 2006·17 cites·34 claims
- 1387US9999609B2Methods for treating or preventing fatigueSK BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jun 19, 2018·2 cites·17 claims
- 1483US9464041B2Methods for treating or preventing fatigueSK BIOPHARMACEUTICALS CO LTD·Filed 2014·Granted Oct 11, 2016·4 cites·28 claims
- 1580US6586427B2Treatments for nervous disordersUPJOHN CO·Filed 2001·Granted Jul 1, 2003·10 cites·1 claims
- 1678US6352986B1Treatments for nervous disordersUPJOHN CO·Filed 2000·Granted Mar 5, 2002·11 cites·7 claims
- 1775US6500827B2Drug combinationsUPJOHN CO·Filed 2001·Granted Dec 31, 2002·3 cites·10 claims
- 1875US2020061017A1Methods for treating or preventing fatigueSK BIOPHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 1971US10507192B2Methods for treating or preventing fatigue using O-carbamoyl-phenylalaninol compoundsSK BIOPHARMACEUTICALS CO LTD·Filed 2018·Granted Dec 17, 2019·0 cites·8 claims
- 2070US2009247528A1Method of treating attention deficit disorderPFIZER·Filed 2009·Application pending·0 cites
- 2168US5055470AMethod of treatment of ischemia in brainBRISTOL MYERS SQUIBB CO·Filed 1989·Granted Oct 8, 1991·16 cites·11 claims
- 2268US2007149527A1New treatments for nervous disordersUPJOHN CO·Filed 2007·Application pending·0 cites
- 2363US2006264436A1Method of Treating a Psychotic DisorderUPJOHN CO·Filed 2006·Application pending·0 cites
- 2461US2003232829A1Treatments for nervous disordersFiled 2003·Application pending·0 cites
- 2560US2003078262A1New drug combinationsUPJOHN CO·Filed 2002·Application pending·0 cites
- 2659US2004058925A1Method of treating fibromyalgia and other somatoform disordersUPJOHN CO·Filed 2003·Application pending·0 cites
- 2757US2002016325A1New drug combinationsFiled 2001·Application pending·0 cites
- 2856US2005187278A1Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitorsPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 2956US2003040464A1Method of treating or preventing attention defecit hyperactivity disorderUPJOHN CO·Filed 2002·Application pending·0 cites
- 3053US2005080083A1Compositions of a cyclooxygenase-2 selective inhibitor and an angiotensin II receptor antagonist for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3153US2005101597A1Compositions of a cyclooxygenase-2 selective inhibitior and a non-NMDA glutamate modulator for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3252US2005159403A1Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3352US2004229803A1Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of pain, inflammation or inflammation mediated disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3452US2004224940A1Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3552US2004220187A1Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of pain, inflammation or inflammation mediated disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3652US2005159419A1Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3752US2006135506A1Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3852US2005054646A1Compositions of a cyclooxygenase-2 selective inhibitor and an antioxidant agent for the treatment of central nervous system disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 3952US2006160776A1Compositions of a cyclooxygenase-2 selective inhibitor and a cannabinoid agent for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 4052US2005070524A1Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disordersPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 4152US2005101629A1Compositions of a chromene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 4252US2005009733A1Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damagePHARMACIA CORP·Filed 2004·Application pending·0 cites
- 4351US2004147581A1Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapyPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 4451US2004171664A1Compositions of cyclooxygenase-2 selective inhibitors and selective serotonin reuptake inhibitors for the treatment or prevention of a vaso-occlusive eventPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 4545US2005148589A1Compositions of a cyclooxygenase-2 selective inhibitor and a neurotrophic factor-modulating agent for the treatment of central nervous system mediated disordersPHARMACIA & UPJOHN CO LLC·Filed 2004·Application pending·0 cites
- 4643US2005159471A1Compositions of a benzenesulfonamide or methylsulfonylbenzene cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 4743US2005113433A1Compositions of a phenyl acetic acid cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 4843US2005026919A1Compositions of a cyclooxygenase-2 selective inhibitor and a cholinergic agent for the treatment of reduced blood flow or trauma to the central nervous systemPHARMACIA CORP·Filed 2004·Application pending·0 cites
- 4941US6391876B1Reboxetine for treatment obsessive compulsive disorders and panic disorderUPJOHN CO·Filed 1999·Granted May 21, 2002·5 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Duncan Taylor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →